Open access peer-reviewed chapter

A Rational for Novel Anti-NeuroOncology Drugs

By Lee Roy Morgan

Submitted: May 3rd 2012Reviewed: September 28th 2012Published: February 27th 2013

DOI: 10.5772/53889

Downloaded: 1127

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Lee Roy Morgan (February 27th 2013). A Rational for Novel Anti-NeuroOncology Drugs, Evolution of the Molecular Biology of Brain Tumors and the Therapeutic Implications, Terry Lichtor, IntechOpen, DOI: 10.5772/53889. Available from:

chapter statistics

1127total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Evolution of the Molecular Biology of Brain Tumors and the Therapeutic Implications

Edited by Terry Lichtor

Next chapter

DNA-PK is a Potential Molecular Therapeutic Target for Glioblastoma

By P. O. Carminati, F. S. Donaires, P. R. D. V. Godoy, A. P. Montaldi, J. A. Meador, A.S. Balajee, G. A. Passos and E. T. Sakamoto-Hojo

Related Book

Clinical Management and Evolving Novel Therapeutic Strategies for Patients with Brain Tumors

Edited by Terry Lichtor

First chapter

Navigated Brain Stimulation (NBS) for Pre-Surgical Planning of Brain Lesion in Critical Areas: Basic Principles and Early Experience

By Concetta Alafaci, Alfredo Conti and Francesco Tomasello

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us